US House keeps heat on J&J recalls as top exec retires
This article was originally published in SRA
Executive Summary
A committee in the US House of Representatives has disclosed plans to hold a hearing on 30 September to once again interrogate Johnson & Johnson executives about the massive recall earlier this year of 136 million bottles of children's over-the-counter medicines, due to quality control issues1,2. Just hours later, J&J announced that the company's long-time senior executive in charge of its consumer group, Colleen Goggins, would be retiring next March3.